This cell line is a CRISPR-corrected isogenic control line for PTEN Hamartoma Tumor Syndrome (PHTS). The Patient-derived PTEN disease model variant iPSC line, BCHi016-A-1, is available from WiCell.

  • Cell Line Alias HNDS0151-01#B CC18(+/+)
  • Unit of Measure (UOM) vial
  • Cell Type Modified Human iPS
  • Sex Female
  • Age at Collection 8 years
  • Ethnicity Information United States. Physician reported
  • Reprogramming Method Non-Integrating - Sendai > Non-Integrating (Sendai: Oct4, Klf4, Sox2, cMyc)
  • Tissue Origin Blood / PBMC > Peripheral Blood Mononuclear Cell
  • Genetic Alteration Mutation Information CRISPR corrected isogenic control
  • Genetic Modification Keyword Isogenic - PTEN Hamartoma Tumor Syndrome (PHTS)
  • Disease PTEN Hamartoma Tumor Syndrome (PHTS)
  • Genetic Alteration Mutation PHTS (isogenic control)
  • hPSCReg ID BCHi016-A-3
  • Provider Boston Children's Hospital - Dr. Elizabeth Buttermore
  • Collections

$1,750.00

$1,750.00

Please log-in to add to your cart.

Lot Number Culture Platform Lot Description Banked By Passage Number Protocol Product Information & Testing
DB68708 StemFlex / Matrigel Provider 18 WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF

WiCell